About this source
- Kind
- Research
- Design
- RCT, Human clinical trial
- Population
- Human adults with moderate to severe dry eye, n=72, single centre, double-masked
- Sample size
- 72
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Neither primary endpoint (ocular discomfort and inferior corneal staining at day 29) showed a significant difference between groups; the positive results were secondary measures. Single centre. Verified from the Europe PMC abstract record.
Cited in
Dry eye Phase II, primary endpoints not met
Thymosin beta-4 · Research finding
LimitedEye-drop trials: few adverse events reported
Thymosin beta-4 · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.